172 results on '"Reddy, Sanjay S."'
Search Results
2. Smoking history is associated with reduced efficacy of neoadjuvant therapy in pancreatic adenocarcinoma
3. Total neoadjuvant therapy for pancreatic adenocarcinoma increases probability for a complete pathologic response
4. Incorporating stereotactic body radiation therapy for inoperable pancreatic cancer.
5. Pulsed low dose rate radiation to mitigate tumor-permissive responses in pancreatic cancer-associated fibroblasts: Introducing the HOST-factor.
6. Treatment at an Academic Cancer Center Confers Better Survival by Stage for Signet-Ring Cell and Non-signet-Ring Cell Gastric Cancer
7. Clinical and Histological Basis of Adenosquamous Carcinoma of the Pancreas: A 30-year Experience
8. Predicting positive peritoneal cytology in pancreatic cancer
9. Tumor mutational burden and somatic mutation status to predict disease recurrence in advanced melanoma
10. Low Frequency of Lymph Node Metastases in Patients in the United States With Early-stage Gastric Cancers That Fulfill Japanese Endoscopic Resection Criteria
11. Soft tissue sarcoma of the extremity: Characterizing symptom duration and outcomes
12. Feasibility of Fitness Tracker Usage to Assess Activity Level and Toxicities in Patients With Colorectal Cancer
13. Randomized Clinical Trials in Pancreatic Cancer
14. Su1442 TOTAL NEOADJUVANT THERAPY AND PATHOLOGIC TREATMENT RESPONSE: DOES CHEMORADIATION SEQUENCING AFFECT DOWNSTAGING IN PANCREATIC CANCER?
15. Endoscopic Ultrasound Improves Identification of Vascular Involvement in Pancreatic Cancer Staging
16. Retroperitoneal Sarcomas
17. Effects of losartan and vitamin D on outcomes in metastatic pancreatic adenocarcinoma.
18. Total Neoadjuvant Treatment for Pancreatic Ductal Adenocarcinoma Is Associated With Limited Lymph Node Yield but Improved Ratio
19. Discrepancies in survival after conversion to open in minimally invasive pancreatoduodenectomy
20. Tips for early career academic surgeons
21. MULTICENTER ANALYSIS OF THE IMPACT OF BILIARY METAL AND PLASTIC STENTS ON PREOPERATIVE STAGING OF PANCREATIC CANCER
22. Total neoadjuvant therapy is associated with improved overall survival and pathologic response in pancreatic adenocarcinoma
23. Tu1478 OPTIMIZING PERIOPERATIVE FLUID MANAGEMENT TO PREDICT POSTPANCREATODUODENECTOMY COMPLICATIONS
24. Mo1389 THE INFLATION-ADJUSTED DECLINE OF MEDICARE REIMBURSMENT IN UPPER GASTROINTESTINAL CANCER SURGERY (2003-2023)
25. 439 SURVIVAL OUTCOMES AFTER ADJUVANT TREATMENT IN UPSTAGED CT2N0 RECTAL CANCER: ARE WE UNDERUTILIZING THERAPY?
26. Tu1473 EFFECTS OF PRE-OPERATIVE STROMAL MODULATING MEDICATIONS ON PANCREATIC CANCER OUTCOMES
27. 829 UNDERSTANDING FRAGMENTED PANCREATIC CANCER CARE IN PATIENTS RECIEVING NEOADJUVANT THERAPY: ARE SOCIODEMOGRAPHIC DISPARITIES PREDICTIVE OF PATIENTS RECEIVING FRAGMENTED CARE?
28. 823 TOTAL NEOADJUVANT THERAPY IN DISTAL PANCREATIC ADENOCARCINOMA: DOES LOCATION IMPACT THERAPY RESPONSE?
29. Partial Gastrectomy is Associated with Improved Overall Survival in Signet-Ring Cell Gastric Cancer
30. Combined Inhibition of AKT and KIT Restores Expression of Programmed Cell Death 4 (PDCD4) in Gastrointestinal Stromal Tumor
31. 301 PANCREATICOJEJUNOSTOMY: INTRODUCING A NOVEL TECHNIQUE WITH LOW PANCREATIC FISTULA RATE
32. Pancreatic cancer in the era of COVID-19 pandemic: Which one is the lesser of two evils?
33. Tu1428 THE IMPACT OF NEOADJUVANT THERAPY ON VASCULAR RESECTION IN PANCREATIC DUCTAL ADENOCARCINOMA
34. Tu1425 PRE-OPERATIVE WEIGHT LOSS - FRIEND OR FOE IN PATIENTS UNDERGOING MAJOR PANCREATIC RESECTION? AN ACS-NSQIP ANALYSIS
35. 1180 SMOKING HISTORY IS ASSOCIATED WITH REDUCED EFFICACY OF NEOADJUVANT THERAPY IN PANCREATIC ADENOCARCINOMA
36. 1173 OPTIMAL TIME TO SURGERY AFTER NEOADJUVANT THERAPY IN PANCREATIC ADENOCARCINOMA: IS THERE AN IDEAL WINDOW?
37. Feasibility of using fitness tracker to assess activity level and toxicities in colorectal cancer (CRC) patients (Pts).
38. Impact of biliary metal and plastic stents on preoperative staging for pancreatic cancer.
39. Retroperitoneal Sarcomas: Does Laterality Matter?
40. Preoperative Opioid Use in Patients Undergoing Surgical Resection for Treatment of Rectal Cancer
41. Perfect Episodes of Care in Pancreatic Surgery
42. En bloc resection of extra-peritoneal soft tissue neoplasms incorporating a type III internal hemipelvectomy: a novel approach
43. Predicting positive peritoneal cytology in pancreatic cancer.
44. Su1372 OUTCOMES OF ENDOSCOPIC SUBMUCOSAL DISSECTION VERSUS SURGERY IN EARLY GASTRIC CANCER MEETING STANDARD AND EXPANDED INDICATIONS: A MULTICENTER NORTH AMERICAN COHORT
45. Stage II and III rectal adenocarcinoma outcomes related to lymphovascular invasion.
46. Evaluating the prognostic significance of lymphovascular invasion in stage II and III colon cancer.
47. HIPEC scoring system: A preoperative model including clinical and radiographic parameters to improve patient selection.
48. Feasibility of using a fitness tracker to assess activity level and toxicity in colorectal cancer patients.
49. “Vein Involvement During Pancreaticoduodenectomy: Is There a Need for Redefinition of Borderline Resectable Disease”: a Commentary on the Article Published by Kelly et al. in the Journal of Gastrointestinal Surgery 17:1209 (2013)
50. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Gastric Metastases.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.